<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00463645</url>
  </required_header>
  <id_info>
    <org_study_id>CM3_adipose</org_study_id>
    <nct_id>NCT00463645</nct_id>
  </id_info>
  <brief_title>Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients</brief_title>
  <official_title>An Open, Mono-Centre Trial to Investigate the Correlation Between the Interstitial and Arterial Blood Concentrations of Glucose During Subcutaneous Glucose Monitoring in Patients With Severe Sepsis at the Medical Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a mono-centre trial performed at the medical ICU at the Medical University Graz.&#xD;
      There will be a study visit (V1) and a follow-up assessment (V2). In the study visit (V1)&#xD;
      arterial blood glucose values will be monitored and subcutaneous sampling of interstitial&#xD;
      fluid (ISF) with microdialysis for glucose determination and with microperfusion for&#xD;
      cytokine-measurement will be performed. The study visit will last for 26 hours starting with&#xD;
      the insertion of two catheters in the abdominal subcutaneous tissue (one microdialysis- and&#xD;
      one microperfusion catheter). The primary hypothesis of the study is: Interstitial fluid&#xD;
      glucose concentration profiles correlates to the arterial blood glucose concentration profile&#xD;
      in patients with severe sepsis in the medical ICU.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">January 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>10</enrollment>
  <condition>Severe Sepsis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>microdialysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>microperfusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in the medical ICU fulfilling criteria for severe sepsis&#xD;
&#xD;
          -  Mechanical ventilation&#xD;
&#xD;
          -  Increased blood glucose levels ( &gt; 120 mg/dL; &gt; 6.7 mM), or requiring insulin&#xD;
             treatment.&#xD;
&#xD;
          -  Age of patients in the range from 18 to 90 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any disease or condition which the Investigator or the treating physician feels would&#xD;
             interfere with the trial or the safety of the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas R. Pieber, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <study_first_submitted>April 19, 2007</study_first_submitted>
  <study_first_submitted_qc>April 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2007</study_first_posted>
  <last_update_submitted>June 5, 2007</last_update_submitted>
  <last_update_submitted_qc>June 5, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

